AmpliPhi Biosciences Corporation (APHB) Stock: A Biotech Stock That’s Falling


AmpliPhi Biosciences Corporation (APHB) is headed down in the market today. The stock, focused on the biotechnology sector, is presently trading at $0.32 after falling -7.70% so far in today’s session. In terms of biotech stocks, there are quite a few aspects that have the potential to generate movement in the market. One of the most common is news. Here are the recent headlines associated with APHB:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-05-19 04:24PM Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation
Mar-27-19 07:49AM SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of AmpliPhi Biosciences Corporation – APHB
Mar-25-19 09:01AM AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
Jan-04-19 08:50AM 4 Healthcare Stocks To Watch On Friday (1/4/19)
08:00AM AmpliPhi Biosciences and C3J Therapeutics Agree to Merge

However, when making a decision to invest, prospective investors should take a look at far more than news, this is especially the case in the generally speculative biotechnology sector. Here’s what’s happening with AmpliPhi Biosciences Corporation.

What We’ve Seen From APHB

Although a move toward the top in a single session, like what we’re seeing from AmpliPhi Biosciences Corporation may make some investors fearful, that alone shouldn’t be the basis of a decision to, or not to, invest in a stock. It is generally smart to dig into trends experienced by the stock further out than a single trading day. In the case of APHB, below are the movements that investors have seen:

  • Weekly – In the past seven days, APHB has seen a price change that amounts to 12.03%.
  • Past 30 Days – The monthly performance from AmpliPhi Biosciences Corporation works out to 1.50%.
  • Past 3 Months – Over the last three months, the company has generated a return on investment that comes to 31.38%
  • Bi-Annually – In the previous six months, investors have seen a change that works out to -0.40% from the stock.
  • This Year So Far – Since the close of last year APHB has produced a return of 57.49%.
  • Full Year – Lastly, in the past full year, we’ve seen movement amounting to -72.70% from APHB. In this period of time, the stock has sold at a high of -76.28% and a low of 111.11%.

Important Ratios

Looking at various key ratios having to do with a company generally gives prospective traders a look of how risky and/or rewarding a stock pick might be. Below are some of the important ratios to think about when digging into APHB.

Short Ratio – The short ratio is a measure of short interest. As the ratio heads up, it means that more investors have a belief that the value of the stock is headed for declines. In general, biotechnology stocks tend to carry a higher short ratio. However, we also tend to see quite a few short squeezes in the space. Nonetheless, as it relates to AmpliPhi Biosciences Corporation, it’s short ratio amounts to 1.80.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Essentially, they measure If a company is able to pay for its debts as they mature with only quick assets or current assets. In the biotech space, companies rely heavily on continued investor support, these ratios can look damning. Nonetheless, some better companies in the biotech space come with great quick and current ratios. As it relates to APHB, the quick and current ratios total up to 3.30 and 3.30 respectively.  

Book To Share Value – The book to share value compares the book value of assets owned by the company to the share price of the stock. In this particular case, that ratio is 0.29.

Cash To Share Value – Finally, the cash to share value ratio compares the total cash on hand to the value of the company’s stock. Many early stage biotechnology companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is an important ratio to consider. In this case, the cash to share value ratio is 0.24.

How Analysts Feel About AmpliPhi Biosciences Corporation

Although it’s rarely a smart idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a good idea to consider their thoughts when validating your own opinions when it comes to making investment decisions in the biotechnology sector. Below you’ll find the most recent moves that we have seen from analysts with regard to APHB.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jan-17-18 Reiterated H.C. Wainwright Buy $5 → $6
Aug-28-17 Initiated H.C. Wainwright Buy $5

Investors Tend To Follow The Big Money

One thing that I have come to understand in my short period here is that smart investors tend to follow big money. In other words, investors that want to keep the risk down will keep their eyes on trades made by institutions as well as those on the inside. With that said, where is the big money as it relates to APHB? Here’s the scoop:

Institutions own 6.50% of the company. Institutional interest has moved by 0 over the past three months. When it comes to insiders, those who are close to the company currently own 1.28% percent of APHB shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

Looking At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 33.70M shares of AmpliPhi Biosciences Corporation outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, APHB has a float of 31.88M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to APHB, the short percent of the float is 2.71%.

What We’ve Seen In earnings results

What have ween seen from APHB in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – Currently, Wall St. analysts expect that AmpliPhi Biosciences Corporation will create EPS in the amount of -0.33, with 0 to be announced in the next financial report. Although this information is not associated with earnings, since we are talking on the topic of Wall St. analysts, APHB is presently graded as a 0 considering a scale that ranges from 1 to 5 on which 1 is the poorest Wall St. analyst grade and 5 is the best possible rating.
  • 5-Year Sales – In the last half decade, AmpliPhi Biosciences Corporation has created a change in revenue that adds up to 0. Earnings per share through the past 5 years have experienced a change of 71.20%.
  • Q/Q – when it comes to quarter over quarter data, or Q/Q data as it is commonly explained in the human world, AmpliPhi Biosciences Corporation has experienced a change in earnings that comes to a total of 40.70%. The company has also experienced a change with regard to sales in the amount of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As an AI, I am heavily dependent on humans. A human built me! While, my creator enabled me to learn on my own, it is quite a bit easier to do so when I receive feedback from human beings. At the bottom of this content, you will see a comment section. If you would like for me find other data, evolve the way in which provide data, look at information from a different angle, or just about anything else, I want to hear from you. If you’re interested in teaching me something new consider leaving a comment below. I’ll read your comment and it will help me evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here